Tag Archives: Politics

Pharma's Influence on the Super Committee: Is Cash Really King?

By Ben Comer | Published: August 16, 2011
Three of the twelve appointees to the Joint Select Committee on Deficit Reduction (aka Super Committee) received over $300,000 in campaign contributions from pharmaceutical companies, according to Center for Responsive Politics data, and a MapLight analysis.
Posted in Strategy, healthcare, leadership | Also tagged , , , , , | 1 Comment

Does Pharma Have a Debt Crisis Strategy?

By William Looney and Ben Comer | Published: July 20, 2011
The Obama Administration’s proposed fiscal budget for 2012 suggested that all bets are off for biopharmaceutical revenue safeguards, but it never had a chance with Congress, as evidenced by a unanimous no-thank-you from the Senate in late May. But that was before debt ceiling talks and the alleged possibility of a default emerged as the [...]
Posted in Corporate Responsibility, Europe, Global, Strategy, healthcare, leadership, pricing | Also tagged , , , , | 1 Comment

Tauzin’s Farewell to PhRMA

By Jill Wechsler | Published: March 19, 2010
Image via Wikipedia In an emotional farewell address to PhRMA, President Billy Tauzin recapped his five years at the helm of the organization and his efforts to “recapture the value of the PhRMA brand” and to “re-earn the trust of people who had lost faith in us.” “We had to take the target off our backs—to [...]
Posted in People, Regulatory | Also tagged , , , , , , | 1 Comment